Ancora Advisors’s BioLife Solutions BLFS Stock Holding History

Ancora Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,500	Closed	-$90K	–	1942
2021 Q1	$90K	Hold	2,500	–	–	﹤0.01%	909
2020 Q4	$100K	Hold	2,500	–	–	﹤0.01%	753
2020 Q3	$72K	Hold	2,500	–	–	﹤0.01%	783
2020 Q2	$41K	Hold	2,500	–	–	﹤0.01%	858
2020 Q1	$24K	Sell	2,500 -13,199	-84%	-$181K	﹤0.01%	1021
2019 Q4	$254K	Sell	15,699 -130	-0.8%	-$2.11K	0.01%	612
2019 Q3	$264K	Sell	15,829 -14,521	-48%	-$273K	0.01%	554
2019 Q2	$514K	Buy	30,350 +13,470	+80%	+$235K	0.02%	417
2019 Q1	$302K	Buy	+16,880	New	+$268K	0.01%	502
2018 Q4	–	Sell	-2,500	Closed	-$44K	–	678
2018 Q3	$44K	Buy	+2,500	New	+$49.5K	﹤0.01%	913
2017 Q1	–	Sell	-2,500	Closed	-$4K	–	663
2016 Q4	$4K	Buy	+2,500	New	+$4.04K	﹤0.01%	1133

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ancora Advisors's BLFS Position: Q2 2021 in Review

Ancora Advisors sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 2,500 shares — an estimated $90K sold.

Ancora Advisors first reported a position in BLFS in Q4 2016 and held it in 11 quarters. The position peaked at $514K in Q2 2019. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

Ancora Advisors reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
Ancora Advisors sold 2,500 BioLife Solutions shares in Q2 2021, an estimated $90K.
Ancora Advisors first reported a position in BioLife Solutions in Q4 2016 and held it in 11 quarters.
Ancora Advisors's BioLife Solutions position peaked at $514K in Q2 2019.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Ancora Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.